The panel highlights the need for continued research, collaboration between stakeholders, and a strategic approach to leveraging mRNA's capabilities to address unmet clinical needs.
The panel discussed the current state of mRNA medicine, highlighting gaps in research and development, and the need for continued innovation to improve safety and efficacy. The panelists also spoke on the importance of real-world clinical data and collaboration among stakeholders.
Discussion Topics
00:07 - Current state and future potential of the mRNA field
00:28 - Continued research needed to address gaps in mRNA technology, such as delivery mechanisms, immunogenicity, and long-term safety
01:18 - Importance of real-world clinical data and building trust through collaboration between stakeholders
03:37 - Need for a consortium of patient advocates, pharma, biotech, academia, and regulators to accelerate progress in mRNA medicine
03:45 - Excitement about the potential of mRNA technology and the need to use it wisely to push boundaries